scholarly journals Discriminating lineages of Batrachochytrium dendrobatidis using quantitative PCR

Author(s):  
Pria N Ghosh ◽  
Ruhan Verster ◽  
Thomas R Sewell ◽  
Simon J O’Hanlon ◽  
Lola M Brookes ◽  
...  
2007 ◽  
Vol 77 ◽  
pp. 11-15 ◽  
Author(s):  
JD Kirshtein ◽  
CW Anderson ◽  
JS Wood ◽  
JE Longcore ◽  
MA Voytek

2020 ◽  
Author(s):  
Pria N Ghosh ◽  
Ruhan Verster ◽  
Thomas Sewell ◽  
Simon O’Hanlon ◽  
Lola M Brookes ◽  
...  

AbstractThe ability to detect and monitor infectious disease in a phylogenetically informative manner is critical for their management. Phylogenetically informative diagnostic tests enable patterns of pathogen introduction or changes in the distribution of genotypes to be measured, enabling research into the ecology of the pathogen. Batrachochytrium dendrobatidis (Bd), a causative agent of chytridiomycosis in amphibian populations, emerged worldwide in the 21st century and is composed of six lineages which are display varying levels of virulence in their hosts.Research into the distribution, ecology and pathogenicity of these lineages has been hampered by an inability to type lineage efficiently. Here, we describe a lineage-specific TaqMan qPCR assay that differentiates the two lineages of Bd most commonly associated with chytridiomycosis: BdGPL and BdCAPE. We demonstrate how this assay can be used for the surveillance of wild populations of amphibians in Southern Africa using skin swabs, tissue samples and cultured isolates.


2010 ◽  
Vol 01 (03) ◽  
pp. 144-144
Author(s):  
Alexander Kretzschmar

Der Vorteil einer Konsolidierungstherapie mit 90Yttrium-Ibritumomab-Tiuxetan (Zevalin®) beim follikulären Lymphom (FL) wurde in der FIT-Studie anhand der Verbesserung des progressionsfreien Überlebens belegt. Eine quantitative PCR-Analyse (qPCR) der Studie zeigt nun einen weiteren Vorteil der Konsolidierung mit 90Yttrium- Ibritumomab-Tiuxetan: Der Antikörper führt bei 90% der initial bcl-2- positiven Patienten zur bcl-2- Negativität und parallel zu einer Verlängerung des progressionsfreien Überlebens auf über 40 Monate.


2018 ◽  
Vol 127 (3) ◽  
pp. 243-247 ◽  
Author(s):  
AW Waddle ◽  
M Sai ◽  
JE Levy ◽  
G Rezaei ◽  
F van Breukelen ◽  
...  

2017 ◽  
Vol 126 (1) ◽  
pp. 33-41 ◽  
Author(s):  
SM Whitfield ◽  
G Alvarado ◽  
J Abarca ◽  
H Zumbado ◽  
I Zuñiga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document